- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03111251
Multi-component Interventions to Increase HPV Vaccination in a Network of Pediatric Clinics
May 20, 2020 updated by: Sally Vernon, The University of Texas Health Science Center, Houston
Multi-component Interventions for Patients and Providers to Increase HPV Vaccination in a Network of Pediatric Clinics in Houston, TX
The purpose of the study is to determine the comparative effectiveness of a provider-only intervention and a parent plus provider intervention to increase initiation of HPV vaccination among male and female patients ages 11-17 in a large pediatric clinic network in the greater Houston area.
The hypothesis is that HPV vaccine initiation will be higher in clinics randomized to the parent plus provider intervention compared with clinics randomized to the provider-only intervention.
Study Overview
Status
Completed
Conditions
Study Type
Interventional
Enrollment (Anticipated)
1000
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Texas
-
Houston, Texas, United States, 77030
- The University of Texas Health Science Center at Houston
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
11 years to 17 years (CHILD)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patient at a Texas Children's Pediatrics clinic
- Patient had not initiated the HPV vaccination series at baseline
Exclusion Criteria:
- Patient had completed the HPV vaccination series at baseline
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Provider-only intervention
New provider- and system-level evidence-based strategies for increasing HPV vaccination rates are being implemented throughout the entire clinic network.
This includes provider assessment and feedback, provider reminders, provider education, and patient reminders.
|
Tailored immunization reports highlighting adolescent vaccination rates at the individual, clinic and network levels are distributed by clinic champions every quarter.
Reports track vaccination rates over time and allow physicians to compare their rates to the national goal.
An EHR-based reminder system informs providers when patients are due or overdue for HPV vaccination.
Provider education is being delivered through a comprehensive online continuing education activity that is tailored specifically to physicians, nurses, and clinical staff at TCP practices.
It focuses on HPV vaccination best practices and communicating with parents about the HPV vaccine.
Patient reminders are delivered through MyChart, the clinics' online personal health record system, to inform patients (parents) that they are due or overdue for HPV vaccination.
|
EXPERIMENTAL: Provider plus parent intervention
Clinics randomized to the provider plus parent intervention will receive both the provider intervention and the parent education intervention.
|
Tailored immunization reports highlighting adolescent vaccination rates at the individual, clinic and network levels are distributed by clinic champions every quarter.
Reports track vaccination rates over time and allow physicians to compare their rates to the national goal.
An EHR-based reminder system informs providers when patients are due or overdue for HPV vaccination.
Provider education is being delivered through a comprehensive online continuing education activity that is tailored specifically to physicians, nurses, and clinical staff at TCP practices.
It focuses on HPV vaccination best practices and communicating with parents about the HPV vaccine.
Patient reminders are delivered through MyChart, the clinics' online personal health record system, to inform patients (parents) that they are due or overdue for HPV vaccination.
The parent education intervention (currently in development) will employ innovative strategies to identify and overcome barriers to HPV vaccination.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Change in percent of HPV vaccination initiation
Time Frame: baseline, 3 years
|
baseline, 3 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
March 1, 2015
Primary Completion (ACTUAL)
February 28, 2019
Study Completion (ACTUAL)
February 28, 2019
Study Registration Dates
First Submitted
April 6, 2017
First Submitted That Met QC Criteria
April 6, 2017
First Posted (ACTUAL)
April 12, 2017
Study Record Updates
Last Update Posted (ACTUAL)
May 21, 2020
Last Update Submitted That Met QC Criteria
May 20, 2020
Last Verified
May 1, 2020
More Information
Terms related to this study
Other Study ID Numbers
- HSC-SPH-15-0202
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Human Papillomavirus (HPV)
-
Ann & Robert H Lurie Children's Hospital of ChicagoUnknownHuman Papillomavirus (HPV)United States
-
National Institute for Control of Vaccine and BiologicalsUnknownHuman Papillomavirus (HPV) VaccineVietnam
-
University of FloridaPatient-Centered Outcomes Research Institute; National Cancer Institute (NCI)Not yet recruitingHuman Papillomavirus (HPV) VaccinesUnited States
-
University of PittsburghMerck Sharp & Dohme LLCCompletedQuadrivalent HPV Vaccine | Human Papillomavirus VaccineUnited States
-
Gilead SciencesTerminatedHuman Papillomavirus (HPV) 16+ Relapsed/Refractory CancerUnited States
-
Klein Buendel, Inc.National Cancer Institute (NCI); Indiana University; University of New MexicoCompletedHPV | Human Papillomavirus VirusUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedHuman Papillomavirus (HPV)-Related Malignancies | Recurrent/Metastatic (R/M) Human Papillomavirus (HPV)-Related MalignanciesUnited States
-
GlaxoSmithKlineCompletedHuman Papillomavirus (HPV) InfectionSenegal, Tanzania
-
Merck Sharp & Dohme LLCCompletedHuman Papillomavirus (HPV) Infection
-
Inovio PharmaceuticalsCompletedHuman Papillomavirus (HPV)Puerto Rico, United States
Clinical Trials on Provider assessment and feedback
-
University of California, Los AngelesRAND; Olive View-UCLA Education & Research InstituteActive, not recruitingCardiovascular Diseases | HIVUnited States
-
Dallas VA Medical CenterRecruitingPeripheral Arterial DiseaseUnited States
-
UConn HealthAgency for Healthcare Research and Quality (AHRQ)Completed
-
Cook County HealthCompletedMetabolic Syndrome | Type 2 Diabetes | Pre-DiabetesUnited States
-
University of ChicagoNorthwestern University; Ann & Robert H Lurie Children's Hospital of Chicago; Howard Brown Health Center and other collaboratorsRecruiting
-
Washington University School of MedicineCompleted
-
US Department of Veterans AffairsCompletedAdverse Drug EventsUnited States
-
The Hospital for Sick ChildrenCanadian Institutes of Health Research (CIHR)CompletedQuality of Life | Pediatric Cancer | Symptom ScreeningCanada
-
University of PittsburghNot yet recruitingQuality of Life | Bladder CancerUnited States
-
University of NottinghamHeartlight Systems LimitedCompletedInfant, Newborn, Diseases | Infant, Premature, Diseases | Fetus or Neonate Affected by Cesarean SectionUnited Kingdom